澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

GENETIC SIGNATURES LTD

0.079

-0.005-5.95%

成交量：2.51万

成交额：1,984

市值：1,794.40万

市盈率：-1.28

高：0.079

开：0.079

低：0.079

收：0.084

52周最高：0.430

52周最低：0.051

股本：2.27亿

流通股本：1.88亿

量比：0.31

换手率：0.01%

股息：- -

股息率：- -

每股收益(TTM):-0.062

每股收益(LYR):-0.062

净资产收益率：-32.64%

总资产收益率：-17.27%

市净率：0.50

市盈率(LYR):-1.28

数据加载中...

总览公司新闻资讯公告

概念

新冠治疗股+0.25%

资金流向

资金流入：

资金流出：

新闻资讯

Genetic Signatures拟议合并将以发行GSS证券方式注资，不涉及现金对价

Genetic Signatures召开股东大会审议罢免董事决议

基因签名公司收到BCAL诊断公司请求，要求召开股东大会

BCAL诊断公司：要求罢免Michael Aicher，并提名Forrester与Melki进入GSS董事会

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/GSS.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.079,"timestamp":1791781920000,"preClose":0.084,"halted":0,"volume":25110,"delay":0,"changeRate":-0.059523809523809576,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.0617,"marketStatus":"未开盘","change":-0.005,"latestTime":"10-12 16:12:00 AEDT","open":0.079,"high":0.079,"low":0.079,"amount":1984,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0617,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.084,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":0.30515889954214526,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.079,"auctionPrice":0.079,"auctionVolume":7125,"auction":3,"marketStatus":"盘后竞价","timestamp":1791435914989}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-17.27%","roe":"-32.64%","lyrEps":-0.0617,"volumeRatio":0.30515889954214526,"shares":227138828,"dividePrice":0,"high":0.079,"amplitude":0,"preClose":0.084,"low":0.079,"week52Low":0.051,"pbRate":"0.50","psRate":"0.93","week52High":0.43,"institutionHeld":0,"latestPrice":0.079,"eps":-0.0617,"divideRate":0,"volume":25110,"delay":0,"ttmEps":-0.0617,"open":0.079,"prevYearClose":0.25,"prevWeekClose":0.084,"prevMonthClose":0.078,"prevQuarterClose":0.078,"fiveDayClose":0.079,"twentyDayClose":0.081,"sixtyDayClose":0.067,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1114429036","title":"Genetic Signatures拟议合并将以发行GSS证券方式注资，不涉及现金对价","url":"https://stock-news.laohu8.com/highlight/detail?id=1114429036","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114429036?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 07:28","pubTimestamp":1790033293,"startTime":"0","endTime":"0","summary":"Genetic Signatures——这项拟议中的合并案，其注资途径已明确：通过发行GSS证券来实现，而非采用现金对价方式。这一安排意味着，交易双方在资金结算上将完全绕开现金流的直接转移，转而依托股权交换的结构性框架推进合并进程。总的来说，这是一次结构设计上颇为巧妙的资本运作，其实际成效将依赖于市场对GSS证券的接受度及合并后实体的协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","BK7048","GSS.AU","MAP.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188205108","title":"Genetic Signatures召开股东大会 审议罢免董事决议","url":"https://stock-news.laohu8.com/highlight/detail?id=1188205108","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188205108?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 07:59","pubTimestamp":1789603172,"startTime":"0","endTime":"0","summary":"Genetic Signatures公司宣布，将召开一次股东大会，专门审议一项关于罢免某位董事的决议案。\n此次会议的核心议题，聚焦于是否解除该名董事的职务。公司方面已就此发出正式通知，提请全体股东共同商议并作出决定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177770479","title":"基因签名公司收到BCAL诊断公司请求，要求召开股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1177770479","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177770479?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 07:51","pubTimestamp":1789602669,"startTime":"0","endTime":"0","summary":"基因签名公司（Genetic Signatures）已收到来自BCAL诊断公司的正式请求，要求其董事召开并安排股东大会。这一动态标志着双方关系的重大转折，也预示着可能发生治理层面的关键变动。据悉，BCAL诊断公司依据相关法规条款，向基因签名公司的董事层发出了这一正式提议，旨在推动股东层面的直接对话和决策。此举在资本市场引发广泛关注，投资者正密切留意后续进展，评估此次会议可能对基因签名公司治理结构及战略方向带来的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7501","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173556031","title":"BCAL诊断公司：要求罢免Michael Aicher，并提名Forrester与Melki进入GSS董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1173556031","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173556031?lang=zh_cn&edition=fundamental","pubTime":"2026-09-03 10:42","pubTimestamp":1788403333,"startTime":"0","endTime":"0","summary":"BCAL诊断有限公司已正式提出动议，要求将Michael Aicher从Genetic Signatures Ltd董事会中罢免。与此同时，该公司还力荐Forrester及Melki两位候选人，以期他们能够顺利加入GSS董事会。这一人事调整举措，无疑为GSS公司的治理结构投下了一枚重磅炸弹。BCAL方面显然希望通过此番运作，重塑董事会的权力格局，注入新鲜血液。BCAL此举的深层动因，以及新任董事若顺利上位后将带来怎样的治理新风，均有待市场的进一步观察与解读。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7048","BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GSS.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治疗股","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.002498}]}}